viimane versioon :
19/11/2024
uurimisrühmad - Faculty of pharmacy, State university of Utrecht   pdf  
Holland
ülikool
Faculty of pharmacy, State university of Utrecht
Utrecht
Viited   Viited   (15)  
1
Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy.
Mehta A.M,.Van den Hoven J.M, Rosing H,.Hillebrand M.J.X, Nuijen B,. Huitema A.D.R, Beijnen J.H,.Verwaal V.J. (a.mehta@nki.nl)
Int J Pharm - 2015 - ; 479 : 23-27.
2
Chemical stability of the cardioprotective agent ICRF-187 in infusion fluids.
Beijnen JH, Van Gijn R. ()
J Parenter Sci Technol - 1993 - ; 47: 166-171.
3
Degradation kinetics of the antitumor drug nimustin (ACNU) in aqueous solution.
Van der Houwen, O.AG.J, Beijnen J.H, Bult A, Bekers O, Goossen R.M.J, Underberg W.J.M. ()
Int J Pharm - 1993 - ; 99: 73-78.
4
Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids.
Beijnen JH, van Gijn R, Challa EE, Kaijser GP, Underberg WJM. ()
J Parenter Sci Technol - 1992 - ; 46: 111-116.
5
Chemical and physical stability of etoposide and teniposide in commonly used infusion fluids.
Beijnen JH, Beijnen-Bandhoe U, Dubbelman AC, Van Gijn R, Underberg WJM. ()
J Parenter Sci Technol - 1991 - ; 45: 108-112.
6
Chemical stability of suramin in commonly used infusion fluids.
Beijnen JH, Van Gijn R, Horenblas S, Underberg WJM. ()
Ann Pharmacotherapy - 1990 - ; 24: 1056-1058.
7
Chemical stability of the antitumor mitomycin C in solutions for intravesical instillation.
Beijnen JH, Van Gijn R, Underberg WJM. ()
J Parenter Sci Technol - 1990 - ; 44: 332-335.
8
Stability of vinca alkaloid anticancer drugs in three commonly used infusion fluids.
Beijnen JH, Vendrig DEMM, Underberg WJM. ()
J Parenter Sci Technol - 1989 - ; 43: 84-87.
9
Degradation kinetics of vinblastine sulphate in aqueous solutions.
Vendrig DEMM, Smeets BPGM, Beijnen JH, van der Houwen OAGJ, Holthuis JJM. ()
Int J Pharm - 1988 - ; 43: 131-138.
10
Adsorption of human and porcin insulins to intravenous administration sets.
Tol A, Quik RFP, Thyssen JHH. ()
Pharm Weekbl [Sci] - 1988 - ; 10: 213-216.
11
Stability of intravenous admixtures of doxorubicin and vincristine.
Beijnen JH, Neef C, Meuwissen OJAT, Rutten JJMH, Rosing H, Underberg WJM. ()
Am J Hosp Pharm - 1986 - ; 43: 3022-3027.
12
Aspects of the degradation kinetics of doxorubicin in aqueous solution.
Beijnen JH, van der Houwen OAGJ, Underberg WJM. ()
Int J Pharm - 1986 - ; 32: 123-131.
14
Stability after freezing and thawing of solutions of mitomycin C in plastic minibags for intravesical use.
Stolk LML, Fruijtier A, Umans . ()
Pharm Weekbl [Sci] - 1986 - ; 8: 286-288.
15
Stability of anthracycline antitumour agents in infusion fluids.
Beijnen JH, Rosing H, De Vries PA, Underberg WJM. ()
J Parenter Sci Technol - 1985 - ; 39: 220-222.

ingredientide nimekiri   molekulid uuritud   (16)  
vähiravimite Süsteravim Cyclophosphamide
vähiravimite Süsteravim Daunorubicin hydrochloride
Tsütoprotektiivne  ravim Süsteravim Dexrazoxane hydrochloride
vähiravimite Süsteravim Doxorubicin hydrochloride
vähiravimite Süsteravim Epirubicin hydrochloride
vähiravimite Süsteravim Etoposide
vähiravimite Süsteravim Idarubicin hydrochloride
Hüpoglükeemiline ravim Süsteravim Insulin
vähiravimite Süsteravim Mitomycin
vähiravimite Süsteravim Nimustine
vähiravimite Süsteravim Oxaliplatin
Parasiidivastane ravim Süsteravim Suramin
vähiravimite Süsteravim Teniposide
vähiravimite Süsteravim Vinblastine sulfate
vähiravimite Süsteravim Vincristine sulfate
vähiravimite Süsteravim Vindesine sulfate

  Mentions Légales